Assembly Biosciences ASMB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 15.14 | 113.97 | -1.48 | -10,956 | -10 | |
| 2024Q2 | 13.72 | 113.56 | -1.98 | -12,203 | -11 | |
| 2024Q1 | 13.30 | 118.20 | -1.66 | -10,729 | -9 | |
| 2023Q4 | 9.84 | 114.84 | -1.77 | -12,551 | -11 | |
| 2023Q3 | 10.62 | 104.36 | -3.28 | -15,048 | -14 | |
| 2023Q2 | 13.80 | 103.50 | -3.87 | -17,488 | -17 | |
| 2023Q1 | 10.08 | 103.21 | -4.46 | -19,559 | -19 | |
| 2022Q4 | 15.60 | 102.60 | -5.56 | -22,978 | -22 | |
| 2022Q3 | 19.68 | 101.11 | -5.64 | -23,401 | -23 | |
| 2022Q2 | 25.20 | 100.46 | -6.12 | -24,573 | -24 | |
| 2022Q1 | 24.72 | 100.31 | -5.76 | -23,162 | -23 | |
| 2021Q4 | 27.96 | 100.16 | -16.44 | -62,889 | -60 | |
| 2021Q3 | 41.76 | 100.38 | -4.80 | -18,875 | -19 | |
| 2021Q2 | 46.56 | 100.30 | -6.48 | -23,666 | -24 | |
| 2021Q1 | 55.20 | 100.21 | -8.28 | -27,258 | -27 | |
| 2020Q4 | 72.60 | 100.57 | -13.32 | -39,642 | -39 | |
| 2020Q3 | 197.28 | 120.01 | -1.08 | -4,019 | -3 | |
| 2020Q2 | 279.84 | 90.50 | 2.52 | 6,579 | 7 | |
| 2020Q1 | 177.96 | 103.90 | -9.12 | -27,694 | -27 | |
| 2019Q4 | 245.52 | 103.09 | -11.76 | -28,684 | -27 |